• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Henry Schein Inc.

    5/23/25 5:15:34 PM ET
    $HSIC
    Medical Specialities
    Health Care
    Get the next $HSIC alert in real time by email
    8-K
    HENRY SCHEIN INC false 0001000228 0001000228 2025-05-22 2025-05-22
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 22, 2025

     

     

    Henry Schein, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   0-27078   11-3136595
    (State or other jurisdiction
    of incorporation)
     

    (Commission

    File Number)

      (IRS Employer
    Identification No.)

     

    135 Duryea Road, Melville, New York   11747
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (631) 843-5500

     

    (Former name or former address, if changed since last report.)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, par value $.01 per share   HSIC   The Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.07

    Submission of Matters to a Vote of Security Holders.

    On May 22, 2025, at the Henry Schein, Inc. (the “Company”) 2025 Annual Meeting of Stockholders (the “Annual Meeting”), the Company’s stockholders considered: (1) a proposal to consider approval of the election of twelve directors of the Company for terms expiring in 2026; (2) a proposal to consider approval of Max Lin as a director of the Company for a term expiring in 2026, provided that certain conditions were satisfied (which conditions have been satisfied); (3) a proposal to consider approval of William K. “Dan” Daniel as a director of the Company for a term expiring in 2026, provided that certain conditions were satisfied (which conditions have been satisfied); (4) a proposal to consider approval, by non-binding vote, of the 2024 compensation paid to the Company’s Named Executive Officers (as defined in the proxy statement) (commonly known as a “say-on-pay” proposal); and (5) a proposal to consider the ratification of the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 27, 2025. The voting results at the Annual Meeting, with respect to each of the matters described above, are set forth below.

     

      1.

    The twelve directors of the Company were elected to serve for terms expiring in 2026 based upon the following votes:

     

         For      Against      Abstain      Broker
    Non-Votes
     

    Mohamad Ali

         96,213,579        6,590,237        6,058,005        5,915,043  

    Stanley M. Bergman

         91,800,822        15,920,091        1,140,908        5,915,043  

    Deborah Derby

         94,593,299        8,240,677        6,027,845        5,915,043  

    Carole T. Faig

         96,363,571        6,441,173        6,057,077        5,915,043  

    Joseph L. Herring

         96,393,643        9,159,158        3,309,020        5,915,043  

    Robert J. Hombach

         97,038,087        6,351,699        5,472,035        5,915,043  

    Kurt P. Kuehn

         96,146,297        6,770,674        5,944,850        5,915,043  

    Philip A. Laskawy

         87,702,261        20,581,128        578,432        5,915,043  

    Anne H. Margulies

         96,251,355        6,555,825        6,054,641        5,915,043  

    Scott Serota

         96,301,431        6,503,217        6,057,173        5,915,043  

    Bradley T. Sheares, Ph.D.

         94,327,616        11,153,012        3,381,193        5,915,043  

    Reed V. Tuckson, M.D., FACP

         96,312,524        6,588,964        5,960,333        5,915,043  

     

      2.

    Max Lin was elected as a director of the Company for a term expiring in 2026 based upon the following votes:

     

    For

     

    Against

     

    Abstain

     

    Broker Non-Votes

    108,297,741   445,194   118,886   5,915,043

     

      3.

    William K. “Dan” Daniel was elected as a director of the Company for a term expiring in 2026 based upon the following votes:

     

    For

     

    Against

     

    Abstain

     

    Broker Non-Votes

    108,257,602   478,102   126,117   5,915,043

     

      4.

    The 2024 compensation paid to the Company’s Named Executive Officers, commonly known as the “say-on-pay” proposal, was approved, by non-binding vote, based upon the following votes:

     

    For

     

    Against

     

    Abstain

     

    Broker Non-Votes

    93,338,427   12,176,836   3,346,558   5,915,043

     

      5.

    The selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 27, 2025 was ratified based upon the following votes:

     

    For

     

    Against

     

    Abstain

    107,876,507   3,390,933   3,509,424


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

       

    HENRY SCHEIN, INC.

    (Registrant)

    Date: May 23, 2025   By:  

    /s/ Kelly Murphy

          Kelly Murphy
          Senior Vice President and General Counsel
    Get the next $HSIC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HSIC

    DatePrice TargetRatingAnalyst
    2/14/2025$80.00Equal Weight
    Wells Fargo
    1/6/2025$69.00 → $84.00Underperform → Buy
    BofA Securities
    12/4/2024$75.00Neutral
    Mizuho
    7/22/2024$81.00 → $92.00Neutral → Outperform
    Robert W. Baird
    2/26/2024$78.00Market Perform
    Leerink Partners
    12/12/2023$71.00 → $82.00Neutral → Overweight
    JP Morgan
    11/10/2023$70.00Hold → Buy
    Stifel
    8/8/2022$80.00Sell → Neutral
    UBS
    More analyst ratings

    $HSIC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Updated: Henry Schein to Participate in Upcoming Investor Conference in June

      Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, at 12:50 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With ap

      6/2/25 6:45:00 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

      Patient experience is the differentiator – The Catalyst Index reveals how top practices reduce friction to retain and engage patients Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies transforming performance across the industry. Built on years of trusted benchmarking and informed by Henry Schein One's most connected platform, the fourth annual report, The Catalyst Index, raises the bar by revealing the specific actions that distinguish the top 10% of DSOs and private practices. "We're at a turning point in dentistry," said Dr. Ryan Hungate, Chief Clinical and Strategy Officer, He

      5/20/25 6:30:00 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

      5/16/25 4:10:00 PM ET
      $HSIC
      $KKR
      Medical Specialities
      Health Care
      Investment Managers
      Finance